Latanoprost Kent Pharma Uk (Latanoprost)

Latanoprost binds to FP receptors in the eye’s ciliary body, remodeling the extracellular matrix and enhancing uveoscleral outflow of aqueous humor. This increased drainage reduces intra‑ocular pressure, which is the primary therapeutic goal in glaucoma management.

The dosing regimen for Latanoprost Kent Pharma Uk is determined by the prescribing clinician. Typically, one drop is instilled into the affected eye(s) once daily in the evening, but the exact dose and timing must follow the prescriber’s instructions.

Safety data for latanoprost in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision should be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Latanoprost belongs to the prostaglandin analogue class, which generally offers once‑daily dosing and strong IOP‑lowering efficacy. Compared with beta‑blockers or carbonic anhydrase inhibitors, prostaglandin analogues often have a more convenient dosing schedule and a favorable efficacy profile, though individual response may vary.

Latanoprost ophthalmic solution should be stored at room temperature, below 25 °C, in its original container. Keep the bottle tightly closed, protect it from light and moisture, and discard any product that appears discolored or has been opened beyond the recommended period.

Latanoprost is applied as a single drop into the conjunctival sac of the affected eye(s) once daily, preferably in the evening. The patient should avoid touching the tip of the bottle to the eye or any other surface to maintain sterility.

Serious risks, though rare, include severe allergic reactions, uveitis, corneal edema, paradoxical increase in intra‑ocular pressure, and macular edema. Patients should seek immediate medical attention if they experience sudden vision loss, severe eye pain, or signs of infection.

Latanoprost is contraindicated in patients with known hypersensitivity to latanoprost or any component of the formulation. Caution is also advised for individuals with active ocular infections, severe inflammation, or a history of herpes simplex keratitis.